Skip to content

The effect of tranexamic acid on postoperative delirium in orthopedic patients

Effect of Tranexamic Acid on Postoperative Delirium in Elderly Orthopedic Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120026
Enrollment
Unknown
Registered
2026-03-09
Start date
2026-03-09
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium and cognitive dysfunction

Interventions

TXA group:Intravenous infusion of tranexamic acid.
control group:Intravenous infusion of 0.9%NS

Sponsors

Department of Anesthesiology Anhui No.2 Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 105 Years

Inclusion criteria

Inclusion criteria: 1.Elderly patients with fractures diagnosed by imaging (X-ray or CT) and scheduled for surgery. 2.Patients with American Society of Anesthesiologists (ASA) physical status class I-III.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of psychiatric disorders or long-term use of psychotropic medications (e.g., dementia, schizophrenia), chronic analgesic use, or alcohol abuse; 2. Pre-existing delirium; 3. Known allergy to tranexamic acid or any of its components; 4. Patients with hearing or visual impairment, or recent active thrombotic events such as stroke; 5. Patients with severe infection or communication difficulties preventing completion of cognitive function testing.

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative delirium;

Secondary

MeasureTime frame
Fracture subtype;Duration of delirium;Length of hospital stay;Severity of pain score within 3 days after surgery;30-day all-cause mortality;Serum S100 calcium-binding protein ß;Neuron-specific enolase;C-reactive protein;

Countries

China

Contacts

Public ContactXu Feng

Department of Anesthesiology The NO.2 People's Hospital of Anhui Province

540508303@qq.com+86 138 6599 4325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026